Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v19-FR Version v5-FR
Language French French
Date Updated 2023-04-12 2022-11-29
Drug Identification Number 00644331 00644331
Brand name PRO-AMOX-250 PRO-AMOX-250
Common or Proper name AMOX 250 AMOX 250
Company Name PRO DOC LIMITEE PRO DOC LIMITEE
Ingredients AMOXICILLIN AMOXICILLIN
Strength(s) 250MG 250MG
Dosage form(s) POWDER FOR SUSPENSION POWDER FOR SUSPENSION
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100ml 100ml
ATC code J01CA J01CA
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Other (Please describe in comments) Demand increase for the drug.
Anticipated start date 2022-12-05 2022-12-05
Actual start date 2022-11-29 2022-11-29
Estimated end date 2023-05-03 2023-12-06
Actual end date
Shortage status Actual shortage Anticipated shortage
Tier 3 Status Yes Yes
Company comments was under allocation/ était sous allocation -B.O. 2023/02/08
Health Canada comments